Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
This summary of a study by Deloitte combines a traditional economic impact analysis with targeted assessments of health system impacts of patient support programs and clinical trials as well as…
This study examines and quantifies the value of innovative treatments in Canada to patient lives, the healthcare system and to society. Case studies include: HPV vaccines, Melanoma treatments, treatment for…
IMC proposes a value-based, pan-Canadian rare disease strategy, built in collaboration with provinces, patients, clinicians and industry to fill gaps and meet specific needs….
Stay informed with timely, relevant content on key issues shaping our industry.
